• John Wiley & Sons has recently completed a series of executive RSU vestings and, on May 11, 2026, will transition leadership of its Research division from Jay Flynn to incoming Executive Vice President and General Manager Jessica Kowalski, who joins from Microsoft.
• This leadership change signals Wiley’s push to embed AI and data-driven capabilities more deeply into its research publishing and services portfolio.
• Next, we’ll examine how Kowalski’s AI-focused appointment could influence Wiley’s investment narrative around digital publishing and higher-margin data services.

AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

John Wiley & Sons Investment Narrative Recap

To own John Wiley & Sons, you need to believe its shift toward AI enabled research, Open Access, and digital learning can offset pressures on legacy print and subscription models. The latest wave of RSU vestings and the appointment of AI focused leader Jessica Kowalski do not materially change the near term catalyst around scaling digital and data driven revenues, nor the key risk that evolving AI and open access models could unsettle Wiley’s revenue mix.

The most relevant development is Kowalski’s arrival from Microsoft to lead the Research segment, which sits at the center of Wiley’s Open Access, AI licensing, and data services ambitions. As investors weigh this leadership change against catalysts like expanding AI partnerships and operational efficiency efforts, the core question is whether Wiley can grow higher margin digital and services income fast enough to counter policy, funding, and competitive risks in its traditional research publishing base.

Yet investors also need to be aware that growing pressure for open access and alternative publishing models could...

John Wiley & Sons' narrative projects $1.8 billion revenue and $251.1 million earnings by 2029. This requires 2.3% yearly revenue growth and a roughly $96.7 million earnings increase from $154.4 million today.

Uncover how John Wiley & Sons' forecasts yield a $66.00 fair value, a 62% upside to its current price.

Exploring Other Perspectives

Three members of the Simply Wall St Community currently see Wiley’s fair value between US$55.44 and US$86.06, underscoring how far opinions can diverge. Against that range, the AI content licensing risk in particular could materially affect how sustainably Wiley converts its research franchise into higher margin digital revenue, so it is worth comparing several of these viewpoints before forming your own stance.

Explore 3 other fair value estimates on John Wiley & Sons - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your John Wiley & Sons research is our analysis highlighting 5 key rewards and 2 important warning signs that could impact your investment decision.
• Our free John Wiley & Sons research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate John Wiley & Sons' overall financial health at a glance.

Looking For Alternative Opportunities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 31 best rare earth metal stocks of the very few that mine this essential strategic resource.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.